Immunodeficiency
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Cue BiopharmaBOSTON, MA
1 programAccess to Cue Health COVID-19 Remote testing and treatment for COVID-19N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Cue BiopharmaAccess to Cue Health COVID-19 Remote testing and treatment for COVID-19
CENTOGENEEuropean Alpha-Mannosidosis Participant
Clinical Trials (2)
Total enrollment: 667 patients across 2 trials
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Start: Dec 2022Est. completion: Jun 2024
N/ATerminated
European Alpha-Mannosidosis Participant
Start: Aug 2018Est. completion: May 2022667 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space